Clinical Trials Directory

Trials / Sponsors / Lytix Biopharma AS

Lytix Biopharma AS

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedIntratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma
Advanced Melanoma
Phase 22021-06-01
CompletedLTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)
Soft Tissue Sarcoma
Phase 22018-12-28
CompletedLTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pem
Cancer, Melanoma, Breast Cancer
Phase 12013-11-01
CompletedA Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo
Non-bullous Impetigo
Phase 22013-02-01
CompletedA Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, S
Gram-positive, Skin Infections, Mild Eczema/Dermatoses, Atopic Dermatitis
Phase 22010-09-01
CompletedA Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery
Carcinoma
Phase 12010-08-01
CompletedA Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally C
Nasal Carriers MRSA
Phase 1 / Phase 22010-05-01
CompletedDose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour
Cancer With Transdermal Accessible Tumour
Phase 12010-01-01